Structure and function of neurofibromin

Monographs in Human Genetics

Volumn 16, Issue , 2008, Pages 113-128

  Welti, S ^a   D'Angelo, I ^a   Scheffzek, K ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551511236     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000126561     Document Type: Article

References (102)

1. Scheffzek K, Ahmadian MR, Kabsch W, Wiesmuller L, Lautwein A, et al: The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 1997;277:333-338. (Pubitemid 27450699)
2. Scheffzek K, Ahmadian MR, Wiesmuller L, Kabsch W, Stege P, et al: Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J 1998;17:4313-4327. (Pubitemid 28362622)
3. Scheffzek K, Ahmadian MR, Wittinghofer A: GTPase-activating proteins: helping hands to complement an active site. Trends Biochem Sci 1998;23:257-262. (Pubitemid 28343370)
4. Scheffzek K, Lautwein A, Kabsch W, Ahmadian MR, Wittinghofer A: Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature 1996;384:591-596. (Pubitemid 26415941)
5. Ahmadian MR, Wiesmuller L, Lautwein A, Bischoff FR, Wittinghofer A: Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin. J Biol Chem 1996;271:16409-16415. (Pubitemid 26236267)
6. Ahmadian MR, Stege P, Scheffzek K, Wittinghofer A: Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat Struct Biol 1997;4:686-689.
7. Ahmadian MR, Kiel C, Stege P, Scheffzek K: Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. J Mol Biol 2003;329:699-710. (Pubitemid 36629364)
8. De Clue JE, Cohen BD, Lowy DR: Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci USA 1991;88:9914-9918. (Pubitemid 21915745)
9. Gutmann DH, Collins FS: The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron 1993;10:335-343. (Pubitemid 23111727)
10. Shen MH, Harper PS, Upadhyaya M: Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17. (Pubitemid 26025089)
11. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994;7:353-361. (Pubitemid 24204410)
12. The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, et al: Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 1997;276:791-794. (Pubitemid 27199858)
13. Malhotra R, Ratner N: Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin. J Invest Dermatol 1994;102:812-818. (Pubitemid 24144268)
14. Nordlund M, Gu X, Shipley MT, Ratner N: Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. J Neurosci 1993;13:1588-1600. (Pubitemid 23095401)
15. Roudebush M, Slabe T, Sundaram V, Hoppel CL, Golubic M, Stacey DW: Neurofibromin colocalizes with mitochondria in cultured cells. Exp Cell Res 1997;236:161-172. (Pubitemid 27452360)
16. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, et al: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843-849. (Pubitemid 120035057)
17. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, et al: The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990;63:851-859. (Pubitemid 120035058)
18. Xu GF, Lin B, Tanaka K, Dunn D, Wood D, et al: The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990;63:835-841. (Pubitemid 120035056)
19. Bollag G, McCormick F, Clark R: Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J 1993;12:1923-1927. (Pubitemid 23157708)
20. Hakimi MA, Speicher DW, Shiekhattar R: The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis. J Biol Chem 2002;277:36909-36912.
21. Izawa I, Tamaki N, Saya H: Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett 1996;382:53-59. (Pubitemid 26092233)
22. Mangoura D, Sun Y, Li C, Singh D, Gutmann DH, et al: Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 2006;25:735-745. (Pubitemid 43214700)
23. Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG: Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci 2001;21:3764-3770. (Pubitemid 32466468)
24. Boyanapalli M, Lahoud OB, Messiaen L, Kim B, Anderle De Sylor MS, et al: Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. Biochem Biophys Res Commun 2006;340:1200-1208. (Pubitemid 43083405)
25. De Schepper S, Boucneau JM, Westbroek W, Mommaas M, Onderwater J, et al: Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. J Invest Dermatol 2006;126:653-659. (Pubitemid 43255656)
26. Aravind L, Neuwald AF, Ponting CP: Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling. Curr Biol 1999;9:R195-R197. (Pubitemid 29181825)
27. D'Angelo I, Welti S, Bonneau F, Scheffzek K: A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep 2006;7:174-179.
28. Sermon BA, Lowe PN, Strom M, Eccleston JF: The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin. J Biol Chem 1998;273:9480-9485. (Pubitemid 28183031)
29. Klose A, Ahmadian MR, Schuelke M, Scheffzek K, Hoffmeyer S, et al: Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet 1998;7:1261-1268. (Pubitemid 28383059)
30. Upadhyaya M, Osborn MJ, Maynard J, Kim MR, Tamanoi F, Cooper DN: Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1997;99:88-92. (Pubitemid 26419862)
31. Li Y, Bollag G, Clark R, Stevens J, Conroy L, et al: Somatic mutations in the neurof ibromatosis 1 gene in human tumors. Cell 1992;69:275-281.
32. Ars E, Kruyer H, Morell M, Pros E, Serra E, et al: Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003;40:e82.
33. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, et al: Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 2000;66:790-818. (Pubitemid 30470484)
34. Mattocks C, Baralle D, Tarpey P, Ffrench-Constant C, Bobrow M, Whittaker J: Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain. J Med Genet 2004;41:e48.
35. Lee MJ, Su YN, You HL, Chiou SC, Lin LC, et al: Identification of forty-five novel and twentythree known NF1 mutations in Chinese patients with neurofibromatosis type 1. Hum Mutat 2006;27:832.
36. Han SS, Cooper DN, Upadhyaya MN: Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 2001;109:487-497. (Pubitemid 33089307)
37. De Luca A, Buccino A, Gianni D, Mangino M, Giustini S, et al: NF1 gene analysis based on DHPLC. Hum Mutat 2003;21:171-172.
38. Peters H, Hess D, Fahsold R, Schulke M: A novel mutation L1425P in the GAP-region of the NF1 gene detected by temperature gradient gel electrophoresis (TGGE). Mutation in brief no. 230. Online. Hum Mutat 1999;13:337.
39. Welti S, Fraterman S, D'Angelo I, Wilm M, Scheffzek K: The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J Mol Biol 2007;366:551-562. (Pubitemid 46136212)
40. Phillips SE, Vincent P, Rizzieri KE, Schaaf G, Bankaitis VA, Gaucher EA: The diverse biological functions of phosphatidylinositol transfer proteins in eukaryotes. Crit Rev Biochem Mol Biol 2006;41:21-49. (Pubitemid 43214656)
41. Bankaitis VA, Aitken JR, Cleves AE, Dowhan W: An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 1990;347:561-562.
42. Stocker A, Tomizaki T, Schulze-Briese C, Baumann U: Crystal structure of the human supernatant protein factor. Structure 2002;10:1533-1540. (Pubitemid 35351493)
43. Stocker A, Baumann U: Supernatant protein factor in complex with RRR-alpha-tocopherylquinone: a link between oxidized Vitamin E and cholesterol biosynthesis. J Mol Biol 2003;332:759-765. (Pubitemid 37101364)
44. Min KC, Kovall RA, Hendrickson WA: Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin E deficiency. Proc Natl Acad Sci USA 2003;100:14713-14718. (Pubitemid 37517956)
45. Bomar JM, Benke PJ, Slattery EL, Puttagunta R, Taylor LP, et al: Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat Genet 2003;35:264-269. (Pubitemid 37363181)
46. Hayakawa Y, Itoh M, Yamada A, Mitsuda T, Nakagawa T: Expression and localization of Cayman ataxia-related protein, Caytaxin, is regulated in a developmental-and spatial-dependent manner. Brain Res 2007;1129:100-109. (Pubitemid 46048773)
47. Xiao J, Gong S, Ledoux MS: Caytaxin deficiency disrupts signaling pathways in cerebellar cortex. Neuroscience 2007;144:439-461. (Pubitemid 44856755)
48. Crabb JW, Gaur VP, Garwin GG, Marx SV, Chapline C, et al: Topological and epitope mapping of the cellular retinaldehyde-binding protein from retina. J Biol Chem 1991;266:16674-16683. (Pubitemid 21907852)
49. Saari JC, Crabb JW: Focus on molecules: cellular retinaldehyde-binding protein (CRALBP). Exp Eye Res 2005;81:245-246. (Pubitemid 41208159)
50. Allen-Baume V, Segui B, Cockcroft S: Current thoughts on the phosphatidylinositol transfer protein family. FEBS Lett 2002;531:74-80. (Pubitemid 35232789)
51. Wirtz KW: Phospholipid transfer proteins in perspective. FEBS Lett 2006;580:5436-5441. (Pubitemid 44465896)
52. Alb JG Jr, Cortese JD, Phillips SE, Albin RL, Nagy TR, et al: Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. J Biol Chem 2003;278:33501-33518. (Pubitemid 37055805)
53. Meier R, Tomizaki T, Schulze-Briese C, Baumann U, Stocker A: The molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein. J Mol Biol 2003;331:725-734. (Pubitemid 36937156)
54. Sha B, Phillips SE, Bankaitis VA, Luo M: Crystal structure of the Saccharomyces cerevisiae phosphatidylinositoltransfer protein. Nature 1998;391:506-510. (Pubitemid 28086554)
55. Cleves A, McGee T, Bankaitis V: Phospholipid transfer proteins: a biological debut. Trends Cell Biol 1991;1:30-34. (Pubitemid 121001658)
56. Wirtz KW, Zilversmit DB: Participation of soluble liver proteins in the exchange of membrane phospholipids. Biochim Biophys Acta 1969;193:105-116.
57. Daum G, Paltauf F: Isolation and partial characterization of a phospholipid transfer protein from yeast cytosol. Biochim Biophys Acta 1984;794:385-391.
58. Aitken JF, Van Heusden GP, Temkin M, Dowhan W: The gene encoding the phosphatidylinositol transfer protein is essential for cell growth. J Biol Chem 1990;265:4711-4717.
59. Blomberg N, Baraldi E, Nilges M, Saraste M: The PH superfold: a structural scaffold for multiple functions. Trends Biochem Sci 1999;24:441-445. (Pubitemid 29528206)
60. Lemmon MA: Pleckstrin homology domains: not just for phosphoinositides. Biochem Soc Trans 2004;32:707-711. (Pubitemid 39524359)
61. Itoh T, De Camilli P: Membrane trafficking: dual-key strategy. Nature 2004;429:141-143.
62. Lemmon MA, Ferguson KM, Abrams CS: Pleckstrin homology domains and the cytoskeleton. FEBS Lett 2002;513:71-76. (Pubitemid 34242981)
63. Baumeister MA, Rossman KL, Sondek J, Lemmon MA: The Dbs PH domain contributes independently to membrane targeting and regulation of guanine nucleotide-exchange activity. Biochem J 2006;400:563-572. (Pubitemid 44974468)
64. Godi A, Di Campli A, Konstantakopoulos A, Di Tullio G, Alessi DR, et al: FAPPs control Golgitocell-surface membrane traffic by binding to ARF and PtdIns (4) P. Nat Cell Biol 2004;6:393-404. (Pubitemid 38607499)
65. Varnai P, Lin X, Lee SB, Tuymetova G, Bondeva T, et al: Inositol lipid binding and membrane localization of isolated pleckstrin homology (PH) domains. Studies on the PH domains of phospholipase C delta 1 and p130. J Biol Chem 2002;277:27412-27422. (Pubitemid 34951762)
66. Di Paolo G, De Camilli P: Phosphoinositides in cell regulation and membrane dynamics. Nature 2006;443:651-657. (Pubitemid 44564702)
67. Ball LJ, Jarchau T, Oschkinat H, Walter U: EVH1 domains: structure, function and interactions. FEBS Lett 2002;513:45-52. (Pubitemid 34242977)
68. Duncan RS, Hwang SY, Koulen P: Effects of Vesl/Homer proteins on intracellular signaling. Exp Biol Med (Maywood) 2005;230:527-535. (Pubitemid 41233151)
69. Uhlik MT, Temple B, Bencharit S, Kimple AJ, Siderovski DP, Johnson GL: Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol 2005;345:1-20. (Pubitemid 39572821)
70. Yan KS, Kuti M, Zhou MM: PTB or not PTB - that is the question. FEBS Lett 2002;513:67-70. (Pubitemid 34242980)
71. Takenawa T, Suetsugu S: The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 2007;8:37-48. (Pubitemid 46012013)
72. Fried H, Kutay U: Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci 2003;60:1659-1688. (Pubitemid 37041364)
73. Pemberton LF, Paschal BM: Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 2005;6:187-198. (Pubitemid 40298153)
74. Upadhyaya M, Maynard J, Osborn M, Harper PS: Six novel mutations in the neurofibromatosis type 1 (NF1) gene. Hum Mutat 1997;10:248-250. (Pubitemid 27371687)
75. Jeong SY, Park SJ, Kim HJ: The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1. J Korean Med Sci 2006;21:107-112. (Pubitemid 43269296)
76. Wu R, Lopez-Correa C, Rutkowski JL, Baumbach LL, Glover TW, Legius E: Germline mutations in NF1 patients with malignancies. Genes Chromosomes Cancer 1999;26:376-380. (Pubitemid 29529584)
77. Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, et al: Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet 1993;53:90-95. (Pubitemid 23313739)
78. Chen D, Zhang XY, Shi Y: Identification and functional characterization of hCLS1, a human cardiolipin synthase localized in mitochondria. Biochem J 2006;398:169-176. (Pubitemid 44338473)
79. Chang EC, Philips MR: Spatial segregation of Ras signaling: new evidence from fission yeast. Cell Cycle 2006;5:1936-1939. (Pubitemid 44435298)
80. Ueda S, Kataoka T, Satoh T: Role of the Sec14-like domain of Dbl family exchange factors in the regulation of Rho family GTPases in different subcellular sites. Cell Signal 2004;16:899-906. (Pubitemid 38638780)
81. Kostenko EV, Mahon GM, Cheng L, Whitehead IP: The Sec14 homology domain regulates the cellular distribution and transforming activity of the Rho-specific guanine nucleotide exchange factor Dbs. J Biol Chem 2005;280:2807-2817. (Pubitemid 40189388)
82. Sirokmany G, Szidonya L, Kaldi K, Gaborik Z, Ligeti E, Geiszt M: Sec14 homology domain targets p50RhoGAP to endosomes and provides a link between Rab and Rho GTPases. J Biol Chem 2006;281:6096-6105. (Pubitemid 43847711)
83. Zhao R, Fu X, Li Q, Krantz SB, Zhao ZJ: Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine. J Biol Chem 2003;278:22609-22614. (Pubitemid 36830318)
84. Gebauer D, Li J, Jogl G, Shen Y, Myszka DG, Tong L: Crystal structure of the PH-BEACH domains of human LRBA/BGL. Biochemistry 2004;43:14873-14880. (Pubitemid 39587463)
85. Gervais V, Lamour V, Jawhari A, Frindel F, Wasielewski E, et al: TFIIH contains a PH domain involved in DNA nucleotide excision repair. Nat Struct Mol Biol 2004;11:616-622. (Pubitemid 38823527)
86. Van Demark AP, Blanksma M, Ferris E, Heroux A, Hill CP, Formosa T: The structure of the yFACT Pob3-M domain, its interaction with the DNA replication factor RPA, and a potential role in nucleosome deposition. Mol Cell 2006;22:363-374.
87. Philip F, Guo Y, Scarlata S: Multiple roles of pleckstrin homology domains in phospholipase Cbeta function. FEBS Lett 2002;531:28-32. (Pubitemid 35232780)
88. Illenberger D, Schwald F, Pimmer D, Binder W, Maier G, et al: Stimulation of phospholipase Cbeta2 by the Rho GTPases Cdc42Hs and Rac1. EMBO J 1998;17:6241-6249. (Pubitemid 28497797)
89. Lin YL, Lei YT, Hong CJ, Hsueh YP: Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway. J Cell Biol 2007;177:829-841.
90. Bausch B, Borozdin W, Mautner VF, Hoffmann MM, Boehm D, et al: Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 2007;92:2784-2792. (Pubitemid 47037390)
91. Griffiths S, Thompson P, Frayling I, Upadhyaya M: Molecular diagnosis of neurofibromatosis type 1:2 years experience. Fam Cancer 2007;6:21-34. (Pubitemid 46295293)
92. Hudson J, Wu CL, Tassabehji M, Summers EM, Simon S, et al: Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene. Hum Mutat 1997;9:366-367. (Pubitemid 27157658)
93. Kluwe L, Friedrich RE, Korf B, Fahsold R, Mautner VF: NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas. Hum Mutat 2002;19:309.
94. Krkljus S, Abernathy CR, Johnson JS, Williams CA, Driscoll DJ, et al: Analysis of CpG C-to-T mutations in neurofibromatosis type 1. Mutations in brief no. 129. Online. Hum Mutat 1998;11:411.
95. Messiaen LM, Callens T, Mortier G, Beysen D, Van Den Broucke I, et al: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000;15:541-555. (Pubitemid 30368440)
96. Purandare SM, Lanyon WG, Connor JM: Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum Mol Genet 1994;3:1109-1115. (Pubitemid 24211955)
97. Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, et al: Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998;102:591-597. (Pubitemid 28282590)
98. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, et al: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 1991;11:931-940.
99. Van Den Broucke I, Van Oostveldt P, Coene E, De Paepe A, Messiaen L: Neurofibromin is actively transported to the nucleus. FEBS Lett 2004;560:98-102. (Pubitemid 38264300)
100. Li C, Cheng Y, Gutmann DA, Mangoura D: Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev Brain Res 2001;130:231-248. (Pubitemid 33000087)
101. Feng L, Yunoue S, Tokuo H, Ozawa T, Yhanq D, et al: PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type 1 tumor suppressor neurofibromin. FEBS Lett 2004;557:275-282. (Pubitemid 38115909)
102. Hakimi MA, Speicher DW, Shiekhattar R: The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis. J Biol Chem 2002;277:36909-36912.